Lymphoma

Showing NaN - NaN of 168

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma Trial in United States (rituximab, bortezomib, cyclophosphamide)

Completed
  • Lymphoma
  • rituximab
  • +5 more
  • Anchorage, Alaska
  • +146 more
Oct 3, 2017

Leukemia, Lymphoma, Multiple Myeloma Trial in Boston (Umbilical Cord Blood After Myeloablative Conditioning, Umbilical Cord

Terminated
  • Leukemia
  • +3 more
  • Umbilical Cord Blood After Myeloablative Conditioning
  • Umbilical Cord Blood After Reduced-Intensity Conditioning
  • Boston, Massachusetts
    Tufts Medical Center
May 1, 2017

Leukemia, Lymphoma, Myelodysplastic Syndrome Trial in Boston (Bortezomib, Tacrolimus, Methotrexate)

Completed
  • Leukemia
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
May 23, 2017

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Boston (drug, procedure, radiation)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 20, 2017

Chronic Lymphocytic Leukemia, Lymphoma, Multiple Myeloma Trial in Boston (Plerixafor)

Terminated
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Boston, Massachusetts
    Tufts Medical Center
May 5, 2017

Chemotherapy or Malignancy-Induced Hyperuricemia in

Completed
  • Leukemia
  • +3 more
  • Palo Alto, California
  • +10 more
Apr 24, 2017

Multiple Myeloma, Lymphoma Trial in Boston (Lenalidomide)

Terminated
  • Multiple Myeloma
  • Lymphoma
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Apr 14, 2017

GVHD, Leukemia, Lymphoma Trial in Boston, Minneapolis (drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 30, 2017

Lymphoma Trial in Boston (Allogeneic stem cell transplantation, Fludarabine, Thiotepa)

Withdrawn
  • Lymphoma
  • Allogeneic stem cell transplantation
  • +3 more
  • Boston, Massachusetts
  • +1 more
Mar 21, 2017

Lymphoma Trial in United States (biological, drug, radiation)

Completed
  • Lymphoma
  • rituximab
  • +5 more
  • Mobile, Alabama
  • +91 more
Jan 12, 2017

Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)

Completed
  • Cachexia
  • +3 more
  • Juven
  • Non-Juven Supplement
  • Birmingham, Alabama
  • +249 more
Dec 6, 2016

Lymphoma Trial in United States (fostamatinib)

Completed
  • Lymphoma
  • Los Angeles, California
  • +10 more
Aug 9, 2016

GVHD, Lymphoma Trial in United States (carmustine, melphalan, etoposide)

Completed
  • Graft Versus Host Disease
  • Lymphoma
  • Birmingham, Alabama
  • +47 more
Jul 15, 2016

Lymphoma Trial in Puerto Rico, United States (filgrastim, rituximab, cyclophosphamide)

Completed
  • Lymphoma
  • filgrastim
  • +6 more
  • Anniston, Alabama
  • +80 more
Jul 15, 2016

Lymphoma Trial in Puerto Rico, United States (biological, drug, procedure)

Completed
  • Lymphoma
  • filgrastim
  • +11 more
  • Anniston, Alabama
  • +80 more
Jul 15, 2016

Lymphoma Trial in Puerto Rico, United States (doxorubicin HCl, topotecan HCl)

Completed
  • Lymphoma
  • doxorubicin hydrochloride
  • topotecan hydrochloride
  • Anniston, Alabama
  • +75 more
Jul 12, 2016

Lymphoma Trial in Puerto Rico, United States (gemcitabine HCl, pegylated liposomal doxorubicin HCl, vinorelbine tartrate)

Completed
  • Lymphoma
  • gemcitabine hydrochloride
  • +2 more
  • Anniston, Alabama
  • +75 more
Jul 12, 2016

Lymphoma Trial in United States (filgrastim, cyclophosphamide, doxorubicin HCl)

Completed
  • Lymphoma
  • filgrastim
  • +5 more
  • Birmingham, Alabama
  • +46 more
Jul 12, 2016

Patients With Aggressive Non-Hodgkin's Lymphoma

Completed
  • Lymphoma
  • comparative genomic hybridization
  • +3 more
  • Anniston, Alabama
  • +68 more
Jul 1, 2016

Lymphoma Trial in United States (epratuzumab, rituximab)

Completed
  • Lymphoma
  • epratuzumab
  • rituximab
  • San Diego, California
  • +42 more
Jul 1, 2016

Lymphoma Trial in United States (rituximab, yttrium Y 90 ibritumomab tiuxetan)

Completed
  • Lymphoma
  • rituximab
  • yttrium Y 90 ibritumomab tiuxetan
  • Little Rock, Arkansas
  • +93 more
Jul 1, 2016

Lymphoma Trial in United States (doxorubicin HCl, gemcitabine HCl, vinblastine)

Completed
  • Lymphoma
  • doxorubicin hydrochloride
  • +4 more
  • San Francisco, California
  • +46 more
Jun 30, 2016

Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (sequential cord blood transplantation)

Completed
  • Lymphoma
  • +3 more
  • sequential cord blood transplantation
  • Boston, Massachusetts
  • +1 more
May 9, 2016